Serum ferritin level as a risk factor for hepatocellular carcinoma recurrence after radiofrequency ablation

被引：0
|
作者：
Uchino, Koji [1 ]
Nakagawa, Hayato [1 ]
Tateishi, Ryosuke [1 ]
Kondo, Mayuko [1 ]
Fujiwara, Naoto [1 ]
Minami, Tatsuya [1 ]
Sato, Masaya [1 ]
Enooku, Kenichiro [1 ]
Kondo, Yuji [1 ]
Asaoka, Yoshinari [1 ]
Yoshida, Haruhiko [1 ]
Shiina, Shuichiro [2 ]
Koike, Kazuhiko [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[2] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2164
引用
收藏
页码：1255A / 1255A
页数：1
相关论文
共 50 条
  • [41] The Pattern of Recurrence Associated With the Prognosis of the Patients With Hepatocellular Carcinoma After Radiofrequency Ablation
    Nakamura, Shinichiro
    Nouso, Kazuhiro
    Onishi, Hideki
    Kuwaki, Kenji
    Takeuchi, Yasuto
    Wada, Nozomu
    Morimoto, Yuuki
    Yasunaka, Tetsuya
    Yasunaka, Yuki
    Ikeda, Fusao
    Shiraha, Hidenori
    Takaki, Akinobu
    Yamamoto, Kazuhide
    Okada, Hiroyuki
    GASTROENTEROLOGY, 2016, 150 (04) : S1135 - S1135
  • [42] Local recurrence of hepatocellular carcinoma after radiofrequency ablation associates with the safety margin of the complete ablation
    Nakazawa, T
    HEPATOLOGY, 2005, 42 (04) : 383A - 384A
  • [43] Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma
    Yoo, Jeongin
    Lee, Min Woo
    Lee, Dong Ho
    Lee, Jeong-Hoon
    Han, Joon Koo
    LIVER INTERNATIONAL, 2020, 40 (05) : 1189 - 1200
  • [44] Low P2/MS Value is an Independent Risk Factor for Early Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation Therapy
    Kwak, Min-Sun
    Lee, Jeong-Hoon
    Chung, Goh Eun
    Yu, Su Jong
    Jung, Eun Uk
    Kim, Bo Hyun
    Choi, Dae Hee
    Kim, Hwi Young
    Kim, Se Hyung
    Lee, Jeong Min
    Lee, Jae Young
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    HEPATO-GASTROENTEROLOGY, 2011, 58 (105) : 147 - 152
  • [45] Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment
    Hu, Xiang-Yu
    Li, Li
    Wu, Hong-Tao
    Liu, Ying
    Wang, Bei-Da
    Tang, Ying
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (10) : 1655 - 1660
  • [46] Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
    Livraghi, T
    Lazzaroni, S
    Meloni, F
    Solbiati, L
    BRITISH JOURNAL OF SURGERY, 2005, 92 (07) : 856 - 858
  • [47] Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma
    Peng, Zhen-Wei
    Zhang, Yao-Jun
    Chen, Min-Shan
    Liang, Hui-Hong
    Li, Jin-Qing
    Zhang, Ya-Qi
    Lau, Wan Y.
    SURGICAL ONCOLOGY-OXFORD, 2008, 17 (01): : 23 - 31
  • [48] Response to the Comment on "Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation"
    Lee, Sunyoung
    Kang, Tae Wook
    ANNALS OF SURGERY, 2021, 274 (01) : E102 - E103
  • [49] Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation
    Lee, Dong Ho
    Lee, Jeong Min
    Yoon, Jung Hwan
    Kim, Yoon Jun
    Han, Joon Koo
    RADIOLOGY, 2017, 282 (03) : 880 - 891
  • [50] Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors
    Yang, Yi
    Xin, Yujing
    Ye, Feng
    Liu, Ning
    Zhang, Xinyuan
    Wang, Yanan
    Li, Xiao
    Fan, Qingsheng
    Zhou, Xiang
    Chen, Yi
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2021, 38 (01) : 437 - 446
12345